AbbVie (ABBV) operating income was $15.9B in FY2025 (+17% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2025
$15.9B
+17%
2024
$13.6B
-20%
2023
$17.0B
-10%
2022
$18.9B
+5%
2021
$18.0B
+58%
2020
$11.4B
-19%
2019
$14.0B
+22%
2018
$11.5B
+19%
2017
$9.6B
+3%
2016
$9.4B
+23%
2015
$7.7B
+124%
2014
$3.4B
-40%
2013
$5.7B
-1%
2012
$5.8B
+59%
2011
$3.7B
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$6.4B
Q1 2026
$4.0B
Q4 2025
$4.5B
Q3 2025
$1.9B
Q2 2025
$4.9B
Q1 2025
$3.7B
Q4 2024
$3.0B
Q3 2024
$3.8B
Q2 2024
$4.0B
Q1 2024
$2.8B
Q4 2023
$4.6B
Q3 2023
$4.4B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.